Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amina Chentouf

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
La Tunisie Medicale|March 4, 2022
Depression in patients with epilepsy: screening, diagnosis and managementAmina Chentouf
Acta Neurologica Belgica|March 24, 2022
The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic reviewWefa Boughrara, Amina Chentouf
Epilepsy Research|March 15, 2015
Consanguinity and epilepsy in Oran, Algeria: A case-control studyAmina Chentouf, Randa Talhi, Aicha Dahdouh, et al.
Seizure|September 13, 2015
Familial epilepsy in Algeria: Clinical features and inheritance profilesAmina Chentouf, Aïcha Dahdouh, Michel Guipponi, et al.
CNS & Neurological Disorders Drug Targets|June 11, 2024
Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 PolymorphismsRachda Riffi, Wefa Boughrara, Amina Chentouf, et al.
Neurogenetics|February 15, 2025
ABCB1 c.3435 C > T (rs1045642) as a biomarker for carbamazepine efficacy and toxicity in Algerian patients with epilepsy: initial findings reportRachda Riffi, Wefa Boughrara, Meriem Samia Aberkane, et al.
The Journal of Headache and Pain|July 3, 2026
Profile of migraine patients in Middle East and North Africa (MENA) region: a multi-center studyMona Hussein, Jasem Al-Hashel, Derya Uludüz, et al.
Multiple Sclerosis and Related Disorders|August 9, 2024
Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based studyMaya Zeineddine, Amal Al-Hajje, Pascale Salameh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2024
Safety and effectiveness of disease-modifying therapies after switching from natalizumabMaya Zeineddine, Raed Al-Roughani, Samar Farouk Ahmed, et al.
Human Molecular Genetics|February 19, 2015
Galanin pathogenic mutations in temporal lobe epilepsyMichel Guipponi, Amina Chentouf, Kristin E B Webling, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
La Tunisie Medicale|March 4, 2022
Depression in patients with epilepsy: screening, diagnosis and managementAmina Chentouf
Acta Neurologica Belgica|March 24, 2022
The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic reviewWefa Boughrara, Amina Chentouf
Epilepsy Research|March 15, 2015
Consanguinity and epilepsy in Oran, Algeria: A case-control studyAmina Chentouf, Randa Talhi, Aicha Dahdouh, et al.
Seizure|September 13, 2015
Familial epilepsy in Algeria: Clinical features and inheritance profilesAmina Chentouf, Aïcha Dahdouh, Michel Guipponi, et al.
CNS & Neurological Disorders Drug Targets|June 11, 2024
Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 PolymorphismsRachda Riffi, Wefa Boughrara, Amina Chentouf, et al.
Neurogenetics|February 15, 2025
ABCB1 c.3435 C > T (rs1045642) as a biomarker for carbamazepine efficacy and toxicity in Algerian patients with epilepsy: initial findings reportRachda Riffi, Wefa Boughrara, Meriem Samia Aberkane, et al.
The Journal of Headache and Pain|July 3, 2026
Profile of migraine patients in Middle East and North Africa (MENA) region: a multi-center studyMona Hussein, Jasem Al-Hashel, Derya Uludüz, et al.
Multiple Sclerosis and Related Disorders|August 9, 2024
Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based studyMaya Zeineddine, Amal Al-Hajje, Pascale Salameh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2024
Safety and effectiveness of disease-modifying therapies after switching from natalizumabMaya Zeineddine, Raed Al-Roughani, Samar Farouk Ahmed, et al.
Human Molecular Genetics|February 19, 2015
Galanin pathogenic mutations in temporal lobe epilepsyMichel Guipponi, Amina Chentouf, Kristin E B Webling, et al.
Pageof 2